FOLLOWING:0FOLLOWERS:0
damon987

Author Popular Blog

“Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 “ *Roots Analysis*
2021-05-06 22:37 BY damon987
To order this detailed 500+ page report, please visit this -https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.htmlKey Inclusions§ A det
0 1
More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy
2021-05-06 22:29 BY damon987
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional t
0 0
The stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, * Roots Analysis*
2021-05-06 22:22 BY damon987
Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous);
0 0
The stem cell the With over 280 therapies under evaluation * Roots Analysis *
2021-05-06 22:13 BY damon987
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are curren
0 0
‘‘Microbial Contract Biomanufacturing Market, 2020-2030’’ *Roots Analysis*
2021-05-06 22:04 BY damon987
To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.htmlKey Inclusion
0 9
Manufacturing and support services, for various types of biologics that are manufactured *Roots Analysis*
2021-05-06 21:54 BY damon987
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the developm
0 1
The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 *Roots Analysis*
2021-05-06 21:45 BY damon987
Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platfor
0 0
Microbial contract biomanufacturing market is, growing at a CAGR of 8.7%, *Roots Analysis*
2021-05-06 21:37 BY damon987
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer l
0 0
“Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” *Roots Analysis*
2021-05-06 00:22 BY damon987
To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.htmlKey Inclusions§
0 11
With two approved drugs and close to 300 clinical / preclinical product candidates *Roots Analysis*
2021-05-06 00:15 BY damon987
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with
0 1
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%
2021-05-06 00:10 BY damon987
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolutio
0 14
Bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
2021-05-06 00:01 BY damon987
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially eng
0 1
“Antibody Contract Manufacturing Market, 2020-2030” *Roots Analysis*
2021-05-05 23:55 BY damon987
To order this detailed 285+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.htmlKey Inclusions § A
0 0
Several companies worldwide claim to possess the required expertise *Roots Analysis*
2021-05-05 23:47 BY damon987
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associa
0 0
The antibody contract manufacturing market is estimated to be worth USD 17 billion in 2030, predicts Roots Analysis
2021-05-05 23:40 BY damon987
The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologi
0 0